Edit |   |
---|---|
Antigenic Specificity | SARS-CoV-2 Spike Protein (Bebtelovimab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | n/a |
Isotype | IgG1 lambda |
Format | Protein A purified |
Size | 100 µg, 1 mg, |
Concentration | 1.93 mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein RBD Neutralizing antibody (Bebtelovimab) is a research grade Human monoclonal antibody biosimilar for the detection of SARS-CoV-2/COVID-19 Spike Protein. The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action. |
Immunogen | n/a |
Other Names | Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, COVID19, S, S1, S1-RBD, Spike glycoprotein, Bebtelovimab, LY-CoV1404, LY3853113 |
Gene, Accession # | n/a |
Catalog # | abx376552 |
Price | please inquire |
Order / More Info | SARS-CoV-2 Spike Protein (Bebtelovimab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950